Neoplasms, Colorectal Recruiting Phase 1 / 2 Trials for Nivolumab (DB09035)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03377361An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has SpreadTreatment